Indeed, several studies found that glioma cells immunopositive for the AC133 epitope located in the N-terminal extracellular loop of CD133 manifest greater malignant potential when compared to their AC133-negative (AC133-) counterparts from the same tumor [3, 4, 6]. This evidence concerns the gene PROM1 and glioma.